Journal article
Compensation for cures: Why we should pay a premium for participation in ‘challenge studies’
- Abstract:
-
Antibiotic resistance is one of the most pressing public health problems humanity faces. Research into new classes of antibiotics and new kinds of treatments – including risky experimental treatments such as phage therapy and vaccines – is an important part of improving our ability to treat infectious diseases. In order to aid this research, we will argue that we should permit researchers to pay people any amount of money to compensate for the risks of participating in clinical trials, includ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Bioethics Journal website
- Publication date:
- 2019-05-28
- Acceptance date:
- 2019-03-22
- DOI:
- EISSN:
-
1467-8519
- ISSN:
-
0269-9702
- Source identifiers:
-
984456
Item Description
- Keywords:
- Pubs id:
-
pubs:984456
- UUID:
-
uuid:4e5ae0de-3d24-4f4d-a9cd-e7c8dd2653b9
- Local pid:
- pubs:984456
- Deposit date:
- 2019-03-26
Terms of use
- Copyright holder:
- Anomaly et al
- Copyright date:
- 2019
- Notes:
- © 2019 The Authors Bioethics Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record